Mon, Dec 22, 2014, 11:38 AM EST - U.S. Markets close in 4 hrs 22 mins


% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • pumptracker pumptracker Aug 9, 2012 9:00 AM Flag

    Co-Founder has Liquidated

    The two scientists at the center of the University of Utah’s lawsuit against Alnylam over patented RNA inference technologies are among the world’s top RNA researchers.

    Thomas Tuschl, who heads the Laboratory for RNA Molecular Biology at Rockefeller University in New York City is a co-founder of Cambridge-based Alynlam Pharmaceuticals has recently liquidated all his holdings within the company.

100.76+0.03(+0.03%)11:37 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.